MEAKSS, a synthetic heptapeptide, is emerging as a promising agent for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates potent regenerative effects by regulating key cellular pathways involved in neuronal maintenance. Studies suggest that MEAKSS can promote axon sprouting, {reduceinflammation, and optimize cogni